Read More Pharma Industry News Verastem gets FDA orphan drug status for COPIKTRA for T-Cell lymphoma Verastem Oncology has secured orphan drug designation for COPIKTRA (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K), from… bypharmanewsdailyOctober 7, 2019
